Liang Schweizer

RainDance Technologies, Inc. engages in the development and commercialization of professional laboratory system. It develops and manufactures genomic tools for non-invasive liquid biopsy applications for the research, early detection, treatment of cancer, and inherited and infectious diseases. The company was founded by Andrew Griffiths, Darren R. Link, and Jerome Bibette in 2004 and is headquartered in Billerica, MA.

Capsum SAS manufactures and sells cosmetic products. It offers skin-care serums, make-up, and perfumes. The company was founded by Sébastien Bardon, David Weitz, and Jérôme Bibette in 2008 and is headquartered in Marseille, France.

Hangzhou Bota Biosciences Co., Ltd. is a company that provides biotechnology development and technical consulting services. Hangzhou Bota Biosciences Co., Ltd. is based in Hangzhou, China and was founded in 2019.

Nest.Bio Ventures (Nest.Bio) is a venture capital firm founded in 2017. The firm is headquartered in Cambridge, Massachusetts.

Rootpath Genomics, Inc. engages in the provision of biotechnology services. It develops personalized T cell therapy platform that bridges precision medicine and cancer immunotherapy. The company was founded by Xi Chen, Le Cong, Yinqing Li, Cheryl Cui, and Ely Porter in 2017 and is headquartered in Cambridge, MA.

Arsenal Biosciences, Inc. discovers, develops, and commercializes curative immune cell therapies. It offers cell therapy, cloud computing, computational biology, genome engineering, machine learning, software engineering, and synthetic immunology. The company was founded by Ken E. Drazan, Bradley E. Bernstein, W. Nicholas Haining, Theo Roth, Kole T. Roybal, and E. John Wherry and is headquartered in San Francisco, CA.

Design Pharmaceuticals, Inc. harnesses nature's chemistry to develop breakthrough therapeutics. The company is based in Cambridge, MA. The company uses engineering-inspired biotechnologies to redesign the process of small molecule-based drug discovery and development, saving time and costs. The company's platform is based on ultrahigh-throughput technologies that biomine and test drug-like molecules from nature at unprecedented speed and scale on hundreds of GPCR targets simultaneously. Design Pharmaceuticals' cell-free biosynthesis eliminates the inherent limitations of traditional chemistry or using platforms based on live production strains, further accelerating lead compound optimization. The company's business model aims to build a continuously growing portfolio of joint development and license agreements with pharma partners. The company was founded by Dirk Löffert, Cosmas Giallourakis, Marnix Medema, Rob Nicol, Noah W. Palm, Michael Jewett, Andrew Griffiths. Dirk Löffert has been the CEO since incorporation.

Part of Alten SA, Cmed Clinical Research Services Ltd. is a clinical research organization that provides full or FSP services to biotech and pharma companies for their clinical trials. Founded in 1999, the company is based in Horsham, UK. Cmed is a technology-led CRO with specialty expertise in oncology, cell and gene therapy, rare diseases, data science, and analytics. The British company provides a unique clinical trial project management model where independent professionals work alongside leads and experts to improve the quality of clinical trial data. Cmed supports projects in autoimmune disease, women's health, and other areas.

ICON Clinical Research, Inc. provides research and consulting services. It services include clinical research, biometrics, interactive technologies, laboratory, clinical pharmacology and consulting services. The company was founded by John Climax and Ronan Lambe in 1990 and is headquartered in North Wales, PA

Cmed Group Ltd. provides clinical research services to pharmaceutical and biotechnology companies. Its services include functional based clinical services, regulatory, consulting and product development, data and analytics, medical services, and clinical operations and study start-up services. The company was founded by David Connelly in 2000 and is headquartered in Horsham, the United Kingdom.

Transition Bio, Inc. is a company based in Watertown, MA that is developing technologies for biomolecular condensate analysis. The company's proprietary drug discovery platform, CondensomicsTM, utilizes droplet microfluidics and machine learning to map and modulate condensates in molecular detail. The company's goal is to build a drug discovery engine based on the latest advancements in biophysics and artificial intelligence. Transition Bio has been founded by Sarah Teichmann, David A. Weitz, Peter H. St George-Hyslop, and Tuomas Knowles.

GnuBIO, Inc. develops life science research and clinical diagnostics products. It develops a droplet-based DNA sequencing technology that integrates the entire sample preparation workflow on a chip, from sample capture, PCR, and sequencing to informatics for researchers and clinicians. The company was founded by David A. Weitz, John J. Boyce, IV and Michael P. Weiner and is headquartered in Cambridge, MA.

Materials Research Science & Engineering Center supports interdisciplinary and multidisciplinary research of fundamental and technological importance. The company is headquartered in Cambridge, MA.

The American Physical Society is an organization that offers information on various prizes, awards, fellowships, scholarships, and grants related to physics. The non-profit company is based in College Park, MD. The company also provides programs that aim to improve physics education, impact policy makers, increase diversity, and inform the public.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Kapsera SAS produces alginate capsules, microbial-based bio-fertilizers and bio-pesticides. The company was founded by Antoine Drevelle, Jérôme Bibette, and Édouard Duliège in 2018 and is headquartered in Paris, France.

ADEMTECH SA specializes in developing and manufacturing magnetic nanoparticles for diagnostic and scientific research applications. The firm produces magnetic nanoparticles for concentration, separation, purification, microfluidic device integration and identification of molecules and specific cells. The company was founded in 2000 and is headquartered in Pessac, France.